| 1 |
|
| 2 |
Cosman F, Crittenden DB, Adachi JD, et al. Romosozumab treatment in postmenopausal women with osteoporosis[J]. N Engl J Med, 2016, 375(16): 1532-1543. DOI: 10.1056/NEJMoa1607948.
|
| 3 |
|
| 4 |
|
| 5 |
Nilsson AG, Sundh D, Johansson L, et al. Type 2 diabetes mellitus is associated with better bone microarchitecture but lower bone material strength and poorer physical function in elderly women: a population-based study[J]. J Bone Miner Res, 2017, 32(5):1062-1071. DOI: 10.1002/jbmr.3057.
|
| 6 |
|
| 7 |
宋亚波. ADA发布新版糖尿病视网膜病变指南[J]. 中华医学信息导报, 2017, 32(4):7.
|
| 8 |
|
| 9 |
|
| 10 |
|
| 11 |
Ala M, Jafari RM, Dehpour AR. Diabetes mellitus and osteoporosis correlation: challenges and hopes[J]. Curr Diabetes Rev, 2020, 16(9):984-1001. DOI: 10.2174/1573399816666200324152517.
|
| 12 |
Mohsin S, Baniyas MM, AlDarmaki RS, et al. An update on therapies for the treatment of diabetes-induced osteoporosis[J]. Expert Opin Biol Ther, 2019, 19(9):937-948. DOI: 10.1080/14712598.2019.1618266.
|
| 13 |
|
| 14 |
|
| 15 |
|
| 16 |
|
| 17 |
Bone HG, Wagman RB, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension[J]. Lancet Diabetes Endocrinol, 2017, 5(7):513-523. DOI: 10.1016/S2213-8587(17)30138-9.
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|